Physiology / long-term outcomes

[MO129-004] Efficacy and Safety of Long-term Evolocumab Use in Asian Versus Other Subjects: the FOURIER Trial

^○Anthony C. Keech¹, Peter Sever², Lixin Jiang³, Atsushi Hirayama⁴, Chen Lu⁵, Leslie Tay⁶, Prakash Deedwania⁷, Chung-Wah Siu⁸, Armando Lira Pineda⁵, Donghoon Choi⁹, Min-Ji Charng¹⁰, John Amerena¹¹, Wan Azman Wan Ahmad¹², Vijay Kumar Chopra¹³, Terje Pedersen¹⁴, Robert Giugliano¹⁵, Marc Sabatine¹⁵ (1.University of Sydney, 2.Imperial College London, 3.Fuwai hospital, 4.Osaka Police Hospital, 5.Amgen Inc., 6.Changi General Hospital, 7.UCSF School of Medicine, 8.University of Hong Kong, 9.Yonsei University Health System Severance Hospital, 10.Taipei Veterans General Hospital, 11. Barwon Health Geelong Hospital, 12.University Malaya Medical Centre, 13.Medanta MediCity, 14.University of Oslo, 15.Brigham and Womens Hospital and Harvard Medical School)